Literature DB >> 27278633

Early Postoperative Albumin Administration Contributes to Morbidity After the Fontan Operation.

Hayden J Zaccagni1,2, Jeffrey A Alten3,4, David C Cleveland5, R Tyler Argent6, Mark A Law2, Ayesha S Bryant5, Santiago Borasino1,2.   

Abstract

The Fontan operation has low mortality, but is associated with significant postoperative morbidity, including prolonged chest tube output (PCTO), which is associated with prolonged hospital length of stay (PLOS). We sought to identify variables present early in the clinical course that could predict patients at high risk for PCTO and PLOS. Retrospective data were collected on 84 Fontan (extracardiac conduit) operations from 1/2008 to 12/2013 at a single institution. PCTO was defined as ≥8 days (>75th percentile); PLOS was defined as ≥12 days postoperatively (>75th percentile). Multivariate regression was used to determine covariates associated with PCTO and PLOS. Median age was 3.5 years (IQR 3-5); weight was 14.5 kg (IQR 13-17). There was no mortality. LOS was 9 days (IQR 3-11), and duration of chest tube drainage 6 days (IQR 5-8) at 15 ml/kg/day (IQR 9-20). In univariate analysis, only systemic right ventricle, 24-h 5 % albumin administration, 24-h fluid balance, and 12-h inotrope score were associated with PCTO. In multivariate analysis, only 5 % albumin administration in first 24 h (p < 0.001) and PCTO were independently associated with PLOS. ROC curve analysis showed patients receiving >25 ml/kg of 5 % albumin in first 24-h predicted PLOS (94 % specificity, 93 % sensitivity, AUC = 0.95, p < 0.001). Increased colloid in the first 24-h post-CPB strongly predicts PCTO and PLOS after Fontan operation, potentially providing an early identification of a cohort with unfavorable Fontan physiology. A better understanding of the role of colloid resuscitation after Fontan is necessary, and efforts to reduce perioperative colloid administration could decrease hospital morbidity.

Entities:  

Keywords:  Albumin; Chest tube output; Fontan; Hospital length of stay; Pleural effusion

Mesh:

Substances:

Year:  2016        PMID: 27278633     DOI: 10.1007/s00246-016-1429-0

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  14 in total

1.  Predictors of outcome after the Fontan operation: is hypoplastic left heart syndrome still a risk factor?

Authors:  J William Gaynor; Nancy D Bridges; Mitchell I Cohen; William T Mahle; William M Decampli; James M Steven; Susan C Nicolson; Thomas L Spray
Journal:  J Thorac Cardiovasc Surg       Date:  2002-02       Impact factor: 5.209

2.  Fenestration improves clinical outcome of the fontan procedure: a prospective, randomized study.

Authors:  Matthew S Lemler; William A Scott; Steven R Leonard; Daniel Stromberg; Claudio Ramaciotti
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

3.  Factors related to pleural effusions after Fontan procedure in the era of fenestration.

Authors:  R T Fedderly; B N Whitstone; S J Frisbee; J S Tweddell; S B Litwin
Journal:  Circulation       Date:  2001-09-18       Impact factor: 29.690

4.  Impact of oral sildenafil on exercise performance in children and young adults after the fontan operation: a randomized, double-blind, placebo-controlled, crossover trial.

Authors:  David J Goldberg; Benjamin French; Michael G McBride; Bradley S Marino; Nicole Mirarchi; Brian D Hanna; Gil Wernovsky; Stephen M Paridon; Jack Rychik
Journal:  Circulation       Date:  2011-03-07       Impact factor: 29.690

5.  Interventions associated with minimal fontan mortality.

Authors:  G S Van Arsdell; B W McCrindle; K D Einarson; K J Lee; E Oag; C A Caldarone; W G Williams
Journal:  Ann Thorac Surg       Date:  2000-08       Impact factor: 4.330

6.  Fluid overload in infants following congenital heart surgery.

Authors:  Matthew A Hazle; Robert J Gajarski; Sunkyung Yu; Janet Donohue; Neal B Blatt
Journal:  Pediatr Crit Care Med       Date:  2013-01       Impact factor: 3.624

7.  The modified Fontan procedure and prolonged pleural effusions.

Authors:  Christopher E Mascio; Matthew Wayment; Tarah T Colaizy; Larry T Mahoney; Harold M Burkhart
Journal:  Am Surg       Date:  2009-02       Impact factor: 0.688

8.  Reduced pleural drainage, length of stay, and readmissions using a modified Fontan management protocol.

Authors:  Nancy A Pike; Carol A Okuhara; Joy Toyama; Barbara P Gross; Winfield J Wells; Vaughn A Starnes
Journal:  J Thorac Cardiovasc Surg       Date:  2015-06-26       Impact factor: 5.209

9.  Does the off-pump Fontan procedure ameliorate the volume and duration of pleural and peritoneal effusions?

Authors:  Fumiaki Shikata; Toshikatsu Yagihara; Koji Kagisaki; Ikuo Hagino; Shuichi Shiraishi; Junjiro Kobayashi; Soichiro Kitamura
Journal:  Eur J Cardiothorac Surg       Date:  2008-07-18       Impact factor: 4.191

10.  The Fontan procedure: contemporary techniques have improved long-term outcomes.

Authors:  Yves d'Udekem; Ajay J Iyengar; Andrew D Cochrane; Leeanne E Grigg; James M Ramsay; Gavin R Wheaton; Dan J Penny; Christian P Brizard
Journal:  Circulation       Date:  2007-09-11       Impact factor: 29.690

View more
  2 in total

1.  Prophylactic Opening of the Pleural Cavity for Postoperative Drainage is a Risk Factor for Prolonged Pleural Effusion After a Fontan Operation.

Authors:  Naoki Masaki; Mizumoto Masahiro; Satoshi Matsuo; Sadahiro Sai
Journal:  Pediatr Cardiol       Date:  2019-08-29       Impact factor: 1.655

2.  Routine Sildenafil Does Not Improve Clinical Outcomes After Fontan Operation.

Authors:  J Leslie Gaddis Collins; Mark A Law; Santiago Borasino; W Clinton Erwin; David C Cleveland; Jeffrey A Alten
Journal:  Pediatr Cardiol       Date:  2017-09-07       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.